Two of the most widely used medicinal plants in South Asian traditional medicine may be stronger together than apart when it ...

Lead candidate Nu-3 is a topically formulated Bisphosphocin®, designed to rapidly kill microbes while reducing the risk ...

By David Bautz, PhD NASDAQ: LABT READ THE FULL LABT RESEARCH REPORT Business Update First Patient Dosed in Phase 2a Trial of ...

Lakewood-Amedex Biotherapeutics (NASDAQ:LABT) reported positive preclinical antimicrobial data for Nu-3 against recent clinical isolates from infected diabetic foot ulcers, ahead of Phase 2a topline ...

Lakewood-Amedex Biotherapeutics Inc. announced positive Minimum Inhibitory Concentration (MIC) data from recent clinical isolates for its lead clinical candidate, Nu-3. Nu-3 is currently being ...

Lakewood-Amedex Biotherapeutics Inc., (NASDAQ: LABT, the "Company"), a clinical-stage biotechnology company advancing a novel class of potent, fast-acting, broad-spectrum antimicrobials for infectious ...

We’re more distracted than ever, but it’s not necessarily our fault. Research reports that the sheer number of distractions vying for our attention at any given moment may be at an all-time high. The ...

ANNAPOLIS, MD – Governor Moore today announced a minimum wage increase to $18 an hour for direct Maryland Aviation Administration (MAA) contract workers at Baltimore Washington International (BWI) ...

SEATTLE-- Not since Nov. 13, 2021, has Washington State deployed fewer offensive players than it did in during the 24-10 Apple Cup loss to Washington on Sunday. Injuries at the tight end spot likely ...